Risk Factors and Clinical Profile of Sapovirus-associated Acute Gastroenteritis in Early Childhood: A Nicaraguan Birth Cohort Study.


Journal

The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858

Informations de publication

Date de publication:
01 03 2021
Historique:
pubmed: 20 1 2021
medline: 25 9 2021
entrez: 19 1 2021
Statut: ppublish

Résumé

Sapovirus is increasingly recognized as an important cause of acute gastroenteritis (AGE) in children. We identified risk factors and characterized the clinical profile of sapovirus AGE in a birth cohort in León, Nicaragua. We conducted a case-control study nested within a birth cohort (n = 444). Fieldworkers conducted weekly household AGE surveillance. AGE stools were tested for sapovirus by reverse transcriptase quantitative polymerase chain reaction. For each first sapovirus episode, we selected 2 healthy age-matched controls and estimated independent risk factors of sapovirus AGE using conditional logistic regression. We compared clinical characteristics of sapovirus AGE episodes with episodes associated with other etiologies and identified co-infections with other enteric pathogens. From June 2017 to July 2019, we identified 63 first sapovirus AGE episodes and selected 126 controls. Having contact with an individual with AGE symptoms and vaginal delivery were independent risk factors for sapovirus AGE. All cases experienced diarrhea, lasting a median 6 days; 23% experienced vomiting. Compared with children with AGE due to another etiology, sapovirus AGE was similar in severity, with less reported fever. Most cases experienced co-infections and were more likely than controls to be infected with diarrheagenic Escherichia coli or astrovirus. Sapovirus was a commonly identified AGE etiology in this Central American setting, and symptoms were similar to AGE associated with other etiologies. The association between vaginal delivery and sapovirus is a novel finding. Gut microbiome composition might mediate this relationship, or vaginal delivery might be a proxy for other risk factors. Further investigation into more specific biological mechanisms is warranted.

Sections du résumé

BACKGROUND
Sapovirus is increasingly recognized as an important cause of acute gastroenteritis (AGE) in children. We identified risk factors and characterized the clinical profile of sapovirus AGE in a birth cohort in León, Nicaragua.
METHODS
We conducted a case-control study nested within a birth cohort (n = 444). Fieldworkers conducted weekly household AGE surveillance. AGE stools were tested for sapovirus by reverse transcriptase quantitative polymerase chain reaction. For each first sapovirus episode, we selected 2 healthy age-matched controls and estimated independent risk factors of sapovirus AGE using conditional logistic regression. We compared clinical characteristics of sapovirus AGE episodes with episodes associated with other etiologies and identified co-infections with other enteric pathogens.
RESULTS
From June 2017 to July 2019, we identified 63 first sapovirus AGE episodes and selected 126 controls. Having contact with an individual with AGE symptoms and vaginal delivery were independent risk factors for sapovirus AGE. All cases experienced diarrhea, lasting a median 6 days; 23% experienced vomiting. Compared with children with AGE due to another etiology, sapovirus AGE was similar in severity, with less reported fever. Most cases experienced co-infections and were more likely than controls to be infected with diarrheagenic Escherichia coli or astrovirus.
CONCLUSIONS
Sapovirus was a commonly identified AGE etiology in this Central American setting, and symptoms were similar to AGE associated with other etiologies. The association between vaginal delivery and sapovirus is a novel finding. Gut microbiome composition might mediate this relationship, or vaginal delivery might be a proxy for other risk factors. Further investigation into more specific biological mechanisms is warranted.

Identifiants

pubmed: 33464013
doi: 10.1097/INF.0000000000003015
pii: 00006454-202103000-00009
pmc: PMC7878336
mid: NIHMS1649438
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-226

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010923
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI141744
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127845
Pays : United States

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Chhabra P, Payne DC, Szilagyi PG, et al. Etiology of viral gastroenteritis in children <5 years of age in the United States, 2008-2009. J Infect Dis. 2013;208:790–800.
Page N, Groome MJ, Murray T, et al. Sapovirus prevalence in children less than five years of age hospitalised for diarrhoeal disease in South Africa, 2009-2013. J Clin Virol. 2016;78:82–88.
Matussek A, Dienus O, Djeneba O, et al. Molecular characterization and genetic susceptibility of sapovirus in children with diarrhea in Burkina Faso. Infect Genet Evol. 2015;32:396–400.
Phan TG, Trinh QD, Yagyu F, et al. Outbreak of sapovirus infection among infants and children with acute gastroenteritis in Osaka City, Japan during 2004-2005. J Med Virol. 2006;78:839–846.
Platts-Mills JA, Liu J, Rogawski ET, et al.; MAL-ED Network Investigators. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018;6:e1309–e1318.
Sakai Y, Nakata S, Honma S, et al. Clinical severity of Norwalk virus and Sapporo virus gastroenteritis in children in Hokkaido, Japan. Pediatr Infect Dis J. 2001;20:849–853.
Pang XL, Honma S, Nakata S, et al. Human caliciviruses in acute gastroenteritis of young children in the community. J Infect Dis. 2000;181(suppl 2):S288–S294.
Bucardo F, Reyes Y, Svensson L, et al. Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination. PLoS One. 2014;9:e98201.
Bucardo F, Carlsson B, Nordgren J, et al. Susceptibility of children to sapovirus infections Nicaragua, 2005-2006. Emerg Infect Dis. 2012;18:1875–1878.
Shirato-Horikoshi H, Ogawa S, Wakita T, et al. Binding activity of norovirus and sapovirus to histo-blood group antigens. Arch Virol. 2007;152:457–461.
Oka T, Wang Q, Katayama K, et al. Comprehensive review of human sapoviruses. Clin Microbiol Rev. 2015;28:32–53.
Nenonen NP, Hannoun C, Svensson L, et al. Norovirus GII.4 detection in environmental samples from patient rooms during nosocomial outbreaks. J Clin Microbiol. 2014;52:2352–2358.
de Wit MA, Koopmans MP, van Duynhoven YT. Risk factors for norovirus, Sapporo-like virus, and group A rotavirus gastroenteritis. Emerg Infect Dis. 2003;9:1563–1570.
Oka T, Katayama K, Hansman GS, et al. Detection of human sapovirus by real-time reverse transcription-polymerase chain reaction. J Med Virol. 2006;78:1347–1353.
Liu J, Kabir F, Manneh J, et al. Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study. Lancet Infect Dis. 2014;14:716–724.
World Health Organization. The WHO Child Growth Standards.2018. Available at: https://www.who.int/childgrowth/en/ . Accessed December 19, 2018.
Khan WU, Sellen DW. Zinc Supplementation in the Management of Diarrhoea. e-Library Evid Nutr Actions.2011. World Health Organization; Available at: https://www.who.int/elena/titles/bbc/zinc_diarrhoea/en/ . Accessed April 2, 2020.
Ministerio de Salud. Capitulo 8: diarrea. In: Normativa No. 017: Guía para la Atención Clínica de las Enfermedades y Accidentes más comunes de la Infancia para niños y niñas de 1 mes a 5 años de edad. 2018:Ministerio de Salud de Nicaragua; 177–194.
Liu X, Jahuira H, Gilman RH, et al. Etiological role and repeated infections of sapovirus among children aged less than 2 years in a cohort study in a peri-urban community of Peru. J Clin Microbiol. 2016;54:1598–1604.
Becker-Dreps S, Bucardo F, Vilchez S, et al. Etiology of childhood diarrhea after rotavirus vaccine introduction: a prospective, population-based study in Nicaragua. Pediatr Infect Dis J. 2014;33:1156–1163.
Lindsay B, Ramamurthy T, Sen Gupta S, et al. Diarrheagenic pathogens in polymicrobial infections. Emerg Infect Dis. 2011;17:606–611.
Azevedo M, Mullis Li, Agnihothram S. Viral and bacterial co-infection and its implications. SciFed Virol Res J. 2017;1:10.23959/sfjv-1000002.
Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107:11971–11975.
Hill CJ, Lynch DB, Murphy K, et al. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET cohort. Microbiome. 2017;5:1–18.
Reyman M, van Houten MA, van Baarle D, et al. Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life. Nat Commun. 2019;10:1–12.
Bäckhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690–703.
Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63:559–566.
Mazmanian SK, Liu CH, Tzianabos AO, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107–118.
Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489–493.
Lei S, Twitchell EL, Ramesh AK, et al. Enhanced GII.4 human norovirus infection in gnotobiotic pigs transplanted with a human gut microbiota. J Gen Virol. 2019;100:1530–1540.
Sandall J, Tribe RM, Avery L, et al. Short-term and long-term effects of caesarean section on the health of women and children. Lancet. 2018;392:1349–1357.

Auteurs

Nadja A Vielot (NA)

From the Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Fredman González (F)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Yaoska Reyes (Y)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Omar Zepeda (O)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Bryan Blette (B)

Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Margarita Paniagua (M)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Christian Toval-Ruíz (C)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Marta Diez-Valcarce (M)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Center for Global Safe Water Sanitation and Hygiene, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Michael G Hudgens (MG)

Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Lester Gutiérrez (L)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Patricia Blandón (P)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Roberto Herrera (R)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Edwing Centeno Cuadra (EC)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Natalie Bowman (N)

Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Samuel Vilchez (S)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Jan Vinjé (J)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Sylvia Becker-Dreps (S)

From the Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Filemón Bucardo (F)

Department of Microbiology and Parasitology, National Autonomous University of Nicaragua-León, León, Nicaragua.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH